Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,141	5,022	2,459	2,892	2,400	2,928
Market Cap Growth	70.70%	104.18%	-14.96%	20.51%	-18.04%	-17.35%
Enterprise Value	8,769	5,881	3,259	3,284	3,006	3,403
Last Close Price	4.75	3.34	1.60	1.90	1.52	1.86
PE Ratio	20.37	13.80	11.00	12.63	14.42	30.04
Forward PE	11.05	10.84	7.73	9.24	10.10	13.64
PS Ratio	3.03	1.81	1.28	1.95	1.93	3.05
PB Ratio	7.12	2.42	1.39	1.90	1.78	2.47
P/TBV Ratio	1651.94	3.37	2.10	2.73	2.50	3.02
P/FCF Ratio	-	-	-	-	12.72	-
P/OCF Ratio	-	-	-	98.55	9.94	-
PEG Ratio	-	0.28	0.28	0.28	0.27	0.30
EV/Sales Ratio	3.72	2.12	1.70	2.21	2.41	3.54
EV/EBITDA Ratio	13.32	7.33	6.33	8.14	9.49	14.21
EV/EBIT Ratio	15.34	8.14	7.31	9.60	10.96	18.20
EV/FCF Ratio	-50.75	-	-	-	15.93	-
Debt / Equity Ratio	1.73	0.76	0.63	0.61	0.65	0.79
Debt / EBITDA Ratio	2.63	1.94	2.15	2.28	2.75	3.82
Debt / FCF Ratio	-	-	-	-	4.66	-
Asset Turnover	0.61	0.74	0.64	0.57	0.53	0.47
Inventory Turnover	1.95	2.82	3.13	2.52	2.37	1.98
Quick Ratio	0.67	0.53	0.54	0.62	0.76	0.76
Current Ratio	1.25	1.46	1.47	1.49	1.44	1.51
Return on Equity (ROE)	25.08%	20.89%	15.35%	17.63%	14.24%	9.89%
Return on Assets (ROA)	9.16%	12.00%	9.30%	8.24%	7.34%	5.68%
Return on Capital (ROIC)	12.58%	13.84%	10.43%	9.14%	7.90%	6.13%
Return on Capital Employed (ROCE)	26.10%	33.50%	24.20%	21.50%	19.60%	14.90%
Earnings Yield	4.45%	7.71%	9.96%	8.49%	7.54%	3.83%
FCF Yield	-2.42%	-7.41%	-5.51%	-0.17%	7.86%	-8.51%
Dividend Yield	1.44%	-	4.18%	-	-	-
Payout Ratio	35.52%	31.31%	6.85%	9.89%	8.12%	-
Buyback Yield / Dilution	12.56%	-0.23%	-1.27%	2.62%	-	0.00%
Total Shareholder Return	13.99%	-0.23%	2.91%	2.62%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.